Quantum dots could treat Parkinson’s disease
Injected tiny particles called quantum dots reduce symptoms in mice primed to develop a type of Parkinson’s disease, although tests in people are some years away. Quantum dots are just a few nanometres in size – so small they become subject to some of the strange effects of quantum physics. Unlike most medicines, that makes them tiny enough to pass from the bloodstream into the brain. Byung Hee Hong of Seoul National University in South Korea and his colleagues wondered if they would affect the molecules involved in Parkinson’s. This disease is thought to be caused by a protein called synuclein, found in nerve cells, folding into the wrong shape. This triggers a chain reaction of misfolding in nearby synuclein molecules. The result is a build-up of long strands or “fibrils” of the protein, killing neurons. Hong’s team found that in a dish, quantum dots made from graphene bind to synuclein, stopping it from clumping into new fibres and breaking up existing ones. “We didn’t exp...